1. Xiu, Mengxi, Bao, Wenfang, Wang, Jialin, Li, Yandong, Hai, Yanan. 2023. High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma. In BMC cancer, 23, 1105. doi:10.1186/s12885-023-11617-4. https://pubmed.ncbi.nlm.nih.gov/37957631/
2. Chen, Sifang, Chen, Xi, Li, Zhangyu, Tan, Guowei, Wang, Zhanxiang. 2022. Identification of ubiquitin-specific protease 32 as an oncogene in glioblastoma and the underlying mechanisms. In Scientific reports, 12, 6445. doi:10.1038/s41598-022-09497-y. https://pubmed.ncbi.nlm.nih.gov/35440702/
3. Chandrasekaran, Arun Pandian, Kaushal, Kamini, Park, Chang-Hwan, Kim, Kye-Seong, Ramakrishna, Suresh. 2021. USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2. In Theranostics, 11, 9752-9771. doi:10.7150/thno.63806. https://pubmed.ncbi.nlm.nih.gov/34815782/
4. Hu, Wenyu, Wei, Haiyan, Li, Keming, Lin, Jiamao, Feng, Rui. 2017. Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer. In Cell proliferation, 50, . doi:10.1111/cpr.12343. https://pubmed.ncbi.nlm.nih.gov/28597490/
5. Akhavantabasi, Shiva, Akman, Hesna B, Sapmaz, Aysegul, Petty, Elizabeth M, Erson, Ayse E. 2010. USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers. In Mammalian genome : official journal of the International Mammalian Genome Society, 21, 388-97. doi:10.1007/s00335-010-9268-4. https://pubmed.ncbi.nlm.nih.gov/20549504/
6. Paulding, Charles A, Ruvolo, Maryellen, Haber, Daniel A. 2003. The Tre2 (USP6) oncogene is a hominoid-specific gene. In Proceedings of the National Academy of Sciences of the United States of America, 100, 2507-11. doi:. https://pubmed.ncbi.nlm.nih.gov/12604796/
7. Nakae, Aya, Kodama, Michiko, Okamoto, Toru, Jenkins, Nancy A, Kimura, Tadashi. 2021. Ubiquitin specific peptidase 32 acts as an oncogene in epithelial ovarian cancer by deubiquitylating farnesyl-diphosphate farnesyltransferase 1. In Biochemical and biophysical research communications, 552, 120-127. doi:10.1016/j.bbrc.2021.03.049. https://pubmed.ncbi.nlm.nih.gov/33744759/